EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

KDIGO 2025 Clinical Practice Guideline for ADPKD: a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney

Melanie M Y Chan, Tom Nijenhuis iD, Flavia Galletti, Lucile Figueres, Maria Vanessa Perez Gomez iD, Jan Halbritter iD, Roman-Ulrich Müller iD, Emilie Cornec-Le Gall iD

Nephrology Dialysis Transplantation · 30.10.2026 · 41 (11) · 2083-2090

DOI: 10.1093/ndt/gfag096 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 01.05.2026. Verfasst von Melanie M Y Chan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Laboratory of Medical Sciences, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Polycystic Kidney, Autosomal Dominant, Practice Guidelines as Topic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2025 KDIGO Clinical Practice Guideline for Autosomal Dominant Polycystic Kidney Disease (ADPKD) addresses intracranial aneurysms (ICAs) and other vascular manifestations, an aspect of ADPKD care which is of considerable clinical importance and associated with significant patient anxiety. This commentary from the ERA Working Group Genes & Kidney provides a European perspective on guideline implementation, highlighting key areas requiring action and research. People with ADPKD face a 4–5-fold increased risk of ICA (prevalence ∼12.9%) compared to the general population, yet absolute rupture rates remain low (0.57 per 1000 person-years). The guidelines appropriately emphasize risk-stratified, individualized approaches centered on family history, smoking history, and blood pressure control. Key points include the importance of patient information; selective screening in those with family history of ICA, subarachnoid hemorrhage, or unexplained sudden death; and use of contrast-free magnetic resonnance (MR) angiography as the preferred imaging modality. Rescreening intervals of 5–10 years are suggested for high-risk individuals with negative initial screening. Treatment decisions require multidisciplinary expertise at high-volume centers, balancing rupture risk against intervention complications. Thoracic aortic aneurysms show clear association with ADPKD, warranting family screening when present, while abdominal aortic aneurysms demonstrate no increased prevalence. Patient and clinician education emerges as paramount, moving beyond anxiety-driven approaches toward informed shared decision-making. Future research priorities include leveraging European registries to identify genetic risk modifiers, developing validated risk prediction tools, and establishing whether screening translates to improved clinical outcomes in ADPKD-specific populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracranial AneurysmPolycystic Kidney, Autosomal DominantPractice Guidelines as TopicHumansRisk Factors

Stichwörter der Autor:innen

ADPKDICASAHintracranial aneurysmsubarachnoid hemorrhagethoracic aortic aneurysm

Autor:innen und Institutionen

  • Medical Research Council Laboratory of Medical Sciences, Imperial College London, London, UK.
  • Department of Nephrology, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Nephrology, Research Institute for Medical Innovations and Radboudumc Center of Expertise for Rare Kidney Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • PKD International, Geneva, Switzerland.
  • Service de Néphrologie et Immunologie Clinique, Centre de référence SORARE, Filière ORKID, Centre de référence Filière OSCAR, Nantes, France.
  • Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, F-44000, France.

ORCID-Profile: Tom Nijenhuis, Maria Vanessa Perez Gomez, Jan Halbritter, Roman-Ulrich Müller, Emilie Cornec-Le Gall

Zitieren

APA

Chan, M. M. Y., Nijenhuis, T., Galletti, F., Figueres, L., Perez Gomez, M. V., Halbritter, J., Müller, R. U., & Cornec-Le Gall, E. (2026). KDIGO 2025 Clinical Practice Guideline for ADPKD: a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney. Nephrology Dialysis Transplantation, 41(11), 2083-2090. https://doi.org/10.1093/ndt/gfag096

Vancouver

Chan MMY, Nijenhuis T, Galletti F, Figueres L, Perez Gomez MV, Halbritter J, et al. KDIGO 2025 Clinical Practice Guideline for ADPKD: a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney. Nephrology Dialysis Transplantation. 2026;41(11):2083-2090. doi:10.1093/ndt/gfag096

BibTeX
@article{Chan2026,
  author = {Chan, Melanie M Y and Nijenhuis, Tom and Galletti, Flavia and Figueres, Lucile and Perez Gomez, Maria Vanessa and Halbritter, Jan and Müller, Roman-Ulrich and Cornec-Le Gall, Emilie},
  title = {KDIGO 2025 Clinical Practice Guideline for ADPKD: a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  volume = {41},
  number = {11},
  pages = {2083--2090},
  doi = {10.1093/ndt/gfag096}
}
Kostenlos starten →